A02217 Summary:

BILL NOA02217
 
SAME ASNo Same As
 
SPONSORMontesano (MS)
 
COSPNSR
 
MLTSPNSRMcDonough
 
Add §3346, Pub Health L
 
Requires a doctor to obtain the informed consent of patients prior to prescribing psychiatric drugs notifying the patients of possible adverse effects of the drug.
Go to top    

A02217 Actions:

BILL NOA02217
 
01/17/2017referred to higher education
01/03/2018referred to higher education
05/14/2018held for consideration in higher education
Go to top

A02217 Committee Votes:

HIGHER EDUCATION Chair:Glick DATE:05/14/2018AYE/NAY:18/7 Action: Held for Consideration
GlickAyeSmithNay
GottfriedAyeButlerNay
MageeAyeFitzpatrickNay
EnglebrightAyeRaNay
CahillAyeGarbarinoNay
LiftonAyeNorrisNay
CusickAyeMurrayNay
LupardoAye
Peoples-StokesAye
BrindisiAye
StirpeAye
FahyAye
PichardoAye
SimonAye
McDonaldAye
BichotteAye
HyndmanAye
EpsteinAye

Go to top

A02217 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A02217 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          2217
 
                               2017-2018 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 17, 2017
                                       ___________
 
        Introduced by M. of A. MONTESANO -- Multi-Sponsored by -- M. of A. McDO-
          NOUGH,  McKEVITT  -- read once and referred to the Committee on Higher
          Education
 
        AN ACT to amend the public health law, in relation to requiring  notifi-
          cation  and  the  informed consent of the patient prior to prescribing
          psychiatric drugs

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  The  public health law is amended by adding a new section
     2  3346 to read as follows:
     3    § 3346. Psychiatric drug informed consent. No doctor  shall  prescribe
     4  an antipsychotic, antidepressant, hallucinogen, or mood stabilizer drug,
     5  brand or generic, as defined in section thirty-three hundred six of this
     6  article,  for the treatment of psychiatric disorders or conditions with-
     7  out the prior notification  and  the  signed  informed  consent  of  the
     8  patient  informing  the  patient  of any possible adverse effects of the
     9  drug and the interaction with other medications the patient is currently
    10  prescribed.
    11    § 2. This act shall take effect immediately.
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD06078-01-7
Go to top